BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases.
Bridgebio Pharma stock last closed at $38.36, up 5.33% from the previous day, and has increased 49.73% in one year. It has overperformed other stocks in the Biotechnology industry by 1.27 percentage points. Bridgebio Pharma stock is currently +77.43% from its 52-week low of $21.62, and -2.98% from its 52-week high of $39.54.
There are currently 189.88M shares of BBIO outstanding. The market value of BBIO is $7.28B. In the last 24 hours, 10.46M BBIO shares were traded.
How to Buy Bridgebio Pharma Stock
Wondering how to invest in Bridgebio Pharma stock? Here's how.
Decide where to buy Bridgebio Pharma stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Bridgebio Pharma stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Pick your payment method and add your details.
Analyze Bridgebio Pharma stock: The Bridgebio Pharma ticker symbol is BBIO. Is Bridgebio Pharma stock a good investment? Should you buy shares of BBIO? How do BBIO's underlying business fundamentals look? Do top analysts think Bridgebio Pharma is a good buy? Why has BBIO's stock price moved recently? (Hint: Our stock market research website can help you figure out if BBIO is a good stock to buy).
Place your BBIO purchase: Decide if you will purchase BBIO shares at the current market price or use a limit order to buy BBIO shares at a specific price.
Track your BBIO investment: Create a watchlist to the latest updates on your investment in Bridgebio Pharma stock.
Step 1: Decide where to buy Bridgebio Pharma stock
You need a brokerage account to access the NASDAQ market and buy BBIO stock.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal info so you can invest in BBIO today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Bridgebio Pharma stock
Once you have identified the best place to buy Bridgebio Pharma stock, it's absolutely critical to research their stock prior to investing, so you can wrap your head around the risk and opportunity.
Bridgebio Pharma quick stats
BBIO Price
$38.36
1w %
8.88%
1y %
49.73%
5y %
25.65%
P/E
-10.81x
P/B
-4.42x
P/S
57.25x
PEG
N/A
Revenue
$127.42M
Earnings
-$667.97M
Fore. Rev. Growth
103.22%
Fore. Earn. Growth
N/A
Market Cap
$7.28B
Next Earnings
N/A
Next Dividend
N/A
BBIO Overview
WallStreetZen was designed to help average investors do more in-depth fundamental analysis in less time.
BBIO has $540.60M in cash and short term investments. This is enough to cover its annual cash burn of $500.66M.
BBIO has cash burn of 500662000. It has enough cash and short-term investments to cover this for at least one year.
There are more short-term assets than short-term liabilities on the BBIO balance sheet.
Negative Financial Indicators:
There are more long-term liabilities than short-term assets on the BBIO balance sheet.
BBIO debt to equity ratio of -1.53 is negative.
BBIO profit margin has gone down from -246.2% to -524.2% in the past year.
Total BBIO debt is still negative.
Is it a good time to buy BBIO stock, according to Wall Street analysts?
Out of 10 Equities analysts who monitor BBIO, the consensus analyst rating on BBIO is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest BBIO Analyst Upgrades/Downgrades
Anupam Rama, a bottom 5% analyst from JP Morgan maintains BBIO with a strong buy rating and raises their BBIO price target from $44.00 to $50.00, on Mar 24, 2025.
David Lebovitz, a bottom 14% analyst from Citigroup maintains BBIO with a strong buy rating and raises their BBIO price target from $45.00 to $49.00, on Feb 21, 2025.
Joshua Schimmer, a top 1% analyst from Cantor Fitzgerald reiterates BBIO with a strong buy rating and maintains their BBIO price target from $95.00 to $95.00, on Feb 21, 2025.
Cory Kasimov, a top 20% analyst from Evercore ISI Group maintains BBIO with a buy rating and raises their BBIO price target from $45.00 to $50.00, on Dec 23, 2024.
Geoff Meacham, a bottom 7% analyst from Bank of America maintains BBIO with a strong buy rating and raises their BBIO price target from $42.00 to $45.00, on Nov 25, 2024.
Last year, BBIO revenue was $127.42M. Over the last five year, BBIO's revenue has grown by 25.73% per year. This was slower than the Biotechnology industry average of 45.66%.
No, Bridgebio Pharma doesn't provide an income stream by paying out dividends.
What others are saying about BBIO
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your BBIO purchase
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact price, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you require more info about buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Bridgebio Pharma share?
As of Apr 30, 2025, it costs $38.36 to buy one share of Bridgebio Pharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.261 shares of BBIO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.